Literature DB >> 28325002

Radiomic analysis of multi-contrast brain MRI for the prediction of survival in patients with glioblastoma multiforme.

Ahmad Chaddad, Christian Desrosiers, Matthew Toews.   

Abstract

Image texture features are effective at characterizing the microstructure of cancerous tissues. This paper proposes predicting the survival times of glioblastoma multiforme (GBM) patients using texture features extracted in multi-contrast brain MRI images. Texture features are derived locally from contrast enhancement, necrosis and edema regions in T1-weighted post-contrast and fluid-attenuated inversion-recovery (FLAIR) MRIs, based on the gray-level co-occurrence matrix representation. A statistical analysis based on the Kaplan-Meier method and log-rank test is used to identify the texture features related with the overall survival of GBM patients. Results are presented on a dataset of 39 GBM patients. For FLAIR images, four features (Energy, Correlation, Variance and Inverse of Variance) from contrast enhancement regions and a feature (Homogeneity) from edema regions were shown to be associated with survival times (p-value <; 0.01). Likewise, in T1-weighted images, three features (Energy, Correlation, and Variance) from contrast enhancement regions were found to be useful for predicting the overall survival of GBM patients. These preliminary results show the advantages of texture analysis in predicting the prognosis of GBM patients from multi-contrast brain MRI.

Entities:  

Mesh:

Year:  2016        PMID: 28325002     DOI: 10.1109/EMBC.2016.7591612

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  9 in total

1.  Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.

Authors:  Ahmad Chaddad; Siham Sabri; Tamim Niazi; Bassam Abdulkarim
Journal:  Med Biol Eng Comput       Date:  2018-06-19       Impact factor: 2.602

2.  A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.

Authors:  Ahmad Chaddad; Christian Desrosiers; Lama Hassan; Camel Tanougast
Journal:  Br J Radiol       Date:  2016-10-26       Impact factor: 3.039

3.  Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.

Authors:  Jung Youn Kim; Ji Eun Park; Youngheun Jo; Woo Hyun Shim; Soo Jung Nam; Jeong Hoon Kim; Roh-Eul Yoo; Seung Hong Choi; Ho Sung Kim
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

4.  Predicting survival time of lung cancer patients using radiomic analysis.

Authors:  Ahmad Chaddad; Christian Desrosiers; Matthew Toews; Bassam Abdulkarim
Journal:  Oncotarget       Date:  2017-11-01

5.  MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.

Authors:  Yiming Li; Zenghui Qian; Kaibin Xu; Kai Wang; Xing Fan; Shaowu Li; Tao Jiang; Xing Liu; Yinyan Wang
Journal:  Neuroimage Clin       Date:  2017-10-29       Impact factor: 4.881

6.  Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals.

Authors:  Yangsean Choi; Kook Jin Ahn; Yoonho Nam; Jinhee Jang; Na-Young Shin; Hyun Seok Choi; So-Lyung Jung; Bum-Soo Kim
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

7.  Hippocampus and amygdala radiomic biomarkers for the study of autism spectrum disorder.

Authors:  Ahmad Chaddad; Christian Desrosiers; Lama Hassan; Camel Tanougast
Journal:  BMC Neurosci       Date:  2017-07-11       Impact factor: 3.288

8.  A Multi-parametric MRI-Based Radiomics Signature and a Practical ML Model for Stratifying Glioblastoma Patients Based on Survival Toward Precision Oncology.

Authors:  Alexander F I Osman
Journal:  Front Comput Neurosci       Date:  2019-08-27       Impact factor: 2.380

9.  Texture Analysis in Brain Tumor MR Imaging.

Authors:  Akira Kunimatsu; Koichiro Yasaka; Hiroyuki Akai; Haruto Sugawara; Natsuko Kunimatsu; Osamu Abe
Journal:  Magn Reson Med Sci       Date:  2021-03-10       Impact factor: 2.760

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.